Centhaquin

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameCenthaquin
Drug Alias NameCenthaquine citrateCenthaquineLyfaquinPMZ-2010PMZ-2010 citrate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-1Adrenergic receptors alpha-2
Therapy Area/IndicationsShockPain, PostoperativeHemorrhage +[5] 
Global Approved IndicationsShockPain, PostoperativeHeart Arrest
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2020/05/14
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPharmazz Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmazz IncDr.Reddy's Laboratories Ltd
Inactive CompaniesN/A
Active IndicationsShockPain, PostoperativeHeart Arrest +[4] 
Inactive IndicationsHemorrhage

Other Information

ATC CodeC01CA
Related LinksN/A